CubaHeadlines

PURPOSE 1 Study

PURPOSE 1 Study: Explore groundbreaking research and developments focused on preventive HIV treatments, including recent FDA approval of affordable injections.

Two Annual Injections to Prevent HIV: FDA Approves $40 Generic Version
Two Annual Injections to Prevent HIV: FDA Approves $40 Generic Version

Published on 11/2/2026